These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn. Gonda TA; Hutchins GM Am J Perinatol; 1998; 15(9):539-44. PubMed ID: 9890252 [TBL] [Abstract][Full Text] [Related]
3. 50 Years Ago in TheJournal ofPediatrics. Dunn MS J Pediatr; 2016 Jul; 174():22. PubMed ID: 27346503 [No Abstract] [Full Text] [Related]
4. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study]. Sánchez-Mendiola M; Martínez-Natera OC; Herrera-Maldonado N; Ortega-Arroyo J Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120 [TBL] [Abstract][Full Text] [Related]
5. Review of experimental hyaline membrane disease. Robertson B Diagn Histopathol; 1981; 4(1):49-60. PubMed ID: 7018865 [TBL] [Abstract][Full Text] [Related]
6. Surfactant deficiency in hyaline membrane disease: the story of discovery. Avery ME Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1074-5. PubMed ID: 10764292 [No Abstract] [Full Text] [Related]
8. Hyaline membrane disease. Telling it like it was. Tooley WH Am Rev Respir Dis; 1977 Jun; 115(6 Pt 2):19-28. PubMed ID: 326112 [No Abstract] [Full Text] [Related]
9. Surfactant replacement therapy in newborns with hyaline membrane disease. Grobman DW; Foley MM Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997 [TBL] [Abstract][Full Text] [Related]
10. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources. Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665 [TBL] [Abstract][Full Text] [Related]
11. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study. Victorin LH; Deverajan LV; Curstedt T; Robertson B Biol Neonate; 1990; 58(3):121-6. PubMed ID: 2279046 [TBL] [Abstract][Full Text] [Related]
12. Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Perelman RH; Farrell PM Pediatrics; 1982 Oct; 70(4):570-5. PubMed ID: 7122155 [TBL] [Abstract][Full Text] [Related]
13. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation. Helbich TH; Popow C; Dobner M; Wunderbaldinger P; Zekert M; Herold CJ Eur J Radiol; 1998 Oct; 28(3):243-9. PubMed ID: 9881260 [TBL] [Abstract][Full Text] [Related]
14. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters]. Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary surfactant. I. In immature and mature babies. Hill CM; Brown BD; Morley CJ; Davis JA; Barson AJ Early Hum Dev; 1988 Mar; 16(2-3):143-51. PubMed ID: 3378520 [TBL] [Abstract][Full Text] [Related]
16. The era of pulmonary surfactant from Laplace to nowadays. Parmigiani S; Solari E Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyaline membrane disease by administration of exogenous surfactant]. Bonte F; Dehan M; de Fontanges A; Lindenbaum A; Perret L; Puisieux F Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577 [No Abstract] [Full Text] [Related]